Calvarial doughnut lesions-bone fragility syndrome is a rare genetic condition that causes fragile bones and round “doughnut-like” spots in the skull seen on imaging. People with Calvarial doughnut lesions-bone fragility syndrome often have frequent fractures from minor falls and may have bone pain. It usually starts in childhood or adolescence and tends to be lifelong, but severity can vary. Treatment focuses on preventing fractures, managing pain, and building bone strength with medicines like bisphosphonates, calcium, and vitamin D, plus physical therapy and fall prevention. Most people with Calvarial doughnut lesions-bone fragility syndrome have a normal life span, and regular follow-up with bone health specialists helps reduce complications.
Overview
Calvarial doughnut lesions-bone fragility syndromeSymptoms
Calvarial doughnut lesions-bone fragility syndrome features fragile bones with recurrent fractures from minor falls, often in childhood. Round skull lesions may cause bumps or headaches; some develop hearing problems. Early signs of Calvarial doughnut lesions-bone fragility syndrome include low‑impact fractures.
Outlook and prognosis
Most people with Calvarial doughnut lesions–bone fragility syndrome live full lives, but bone fragility means a higher risk of fractures, especially after minor falls. Early recognition, fall prevention, vitamin D/calcium optimization, and tailored physical therapy can reduce breaks. Regular bone-density checks and prompt fracture care support long‑term mobility and comfort.
Causes and risk factors
Calvarial doughnut lesions-bone fragility syndrome results from changes in the SGMS2 gene and is usually autosomal dominant, though new mutations occur. The key risk factor is having an affected parent. Nutrition, steroid use, and minor trauma may modify fracture risk.
Genetic influences
Genetics are central in Calvarial doughnut lesions-bone fragility syndrome; most cases stem from inherited variants in the SGMS2 gene. These changes disrupt bone strength and skull bone remodeling. Family history matters, and genetic testing can confirm the diagnosis and guide relatives.
Diagnosis
Doctors suspect Calvarial doughnut lesions-bone fragility syndrome from repeated low-impact fractures and skull lesions on X-rays or CT. Genetic tests confirm changes in the SGMS2 gene. The genetic diagnosis of Calvarial doughnut lesions-bone fragility syndrome guides care and testing.
Treatment and drugs
Treatment focuses on preventing fractures, easing pain, and protecting bone. People with Calvarial doughnut lesions-bone fragility syndrome may receive bone-strengthening medicines (like bisphosphonates), vitamin D and calcium, fall-prevention support, and tailored physical therapy. Surgery helps stabilize serious fractures.
Symptoms
Day to day, it can feel like bones that break more easily, sometimes after a simple stumble. Calvarial doughnut lesions-bone fragility syndrome is a rare inherited condition that mainly affects bone strength and the skull. Features vary from person to person and can change over time. Early features of Calvarial doughnut lesions-bone fragility syndrome often include childhood fractures, back pain from small spine cracks, and low bone density found on scans.
Broken bones after minor falls or bumps can happen, often starting in childhood or the teen years. Arms, legs, ribs, or feet may be affected.
Small cracks in the spine can cause mid-back pain and stiffness. Over time, this may lead to a bit of height loss or a rounded upper back.
Clinicians call this osteoporosis, which means the bones have less mineral strength and break more easily. It is often seen on a bone density scan (DXA) and is a core feature of Calvarial doughnut lesions-bone fragility syndrome.
Round, doughnut-like spots can form in the skull bones and are usually found on X-rays or CT scans. These lesions can cause tender bumps or headaches and are a hallmark of Calvarial doughnut lesions-bone fragility syndrome.
How people usually first notice Calvarial doughnut lesions-bone fragility syndrome?
Many families first notice Calvarial doughnut lesions–bone fragility syndrome when a child has fractures after minor bumps or falls, or when X-rays taken for an injury reveal unexpectedly thin, fragile bones. Doctors may also spot the condition early because of round, dense “doughnut-like” areas in the skull on imaging, sometimes found after a head injury or during evaluation for headaches, along with clues like short stature or hearing changes that can emerge in childhood or adolescence. If a parent has similar bone fragility or skull findings, that family history often raises suspicion and helps confirm the first signs of Calvarial doughnut lesions–bone fragility syndrome.
Types of Calvarial doughnut lesions-bone fragility syndrome
Calvarial doughnut lesions–bone fragility syndrome is a rare genetic condition linked to variants in the SGMS2 gene. Different variants in this gene can lead to differences in age at first fracture, skull lesion size, and how much the spine or long bones are affected. Not everyone will experience every type. When people talk about types of Calvarial doughnut lesions–bone fragility syndrome, they often mean variants of the condition tied to specific SGMS2 changes.
Early-fracture variant
Fractures start in early childhood, sometimes with minimal impact during play. Skull “doughnut-like” lesions are usually obvious on scans and may cause scalp tenderness or headaches.
Adolescent-onset variant
Bone fragility first shows up around puberty with stress fractures or back pain. Calvarial lesions are present but smaller, and some notice height loss from spine compression over time.
Milder adult variant
Breaks are less frequent and may follow higher-impact injuries. Skull lesions can be subtle on imaging, and day-to-day function is often preserved between injuries.
What genetics can tell you about symptoms
Some people with calvarial doughnut lesions–bone fragility syndrome have mutations in the SGMS2 gene, which weaken skull bone remodeling and cause round “doughnut-like” skull lesions and lifelong tendency to fractures. These variants can also trigger spine compression fractures, bone pain, and short stature.
Causes and risk factors
Calvarial doughnut lesions-bone fragility syndrome is caused by a change in the SGMS2 gene that weakens bone and skull tissue.
It is often inherited in an autosomal dominant way, so a parent with the gene change can pass it to a child.
Some cases happen as a new change with no family history.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Modifiable risk factors for Calvarial doughnut lesions-bone fragility syndrome include low vitamin D or calcium, little weight-bearing activity, smoking, or long-term steroid use.
Environmental and biological risk factors
Being born with Calvarial doughnut lesions-bone fragility syndrome usually traces back to events very early in development, before birth. Doctors often group risks into internal (biological) and external (environmental). Below are the environmental and biological risk factors researchers consider, and where evidence is limited, we say so.
Older fatherhood is linked to more new changes that can arise when sperm cells are made. This can slightly raise the chance a child is born with Calvarial doughnut lesions-bone fragility syndrome. The effect grows with age, but the absolute risk for any single pregnancy remains low.
Rarely, a small fraction of a parent’s egg or sperm cells carry a change even though the parent is healthy. This hidden variation can increase the chance of Calvarial doughnut lesions-bone fragility syndrome recurring within the same family.
Older maternal age mainly increases the risk of chromosomal conditions rather than rare single-gene conditions like this. No clear link has been shown between maternal age and this syndrome.
No specific environmental exposure has been proven to raise the chance of this syndrome. Everyday pollutants, common household chemicals, and routine X-ray levels have not been linked to higher risk.
Genetic risk factors
Most cases are caused by changes in a single gene, SGMS2, which affects how bones keep their strength. This condition is usually inherited in an autosomal dominant way, meaning a parent with the change has a 50% chance to pass it to each child. Carrying a genetic change doesn’t guarantee the condition will appear. Genetic testing for Calvarial doughnut lesions-bone fragility syndrome can confirm the SGMS2 change and help clarify risks for relatives.
SGMS2 gene change: Most people with this syndrome have a disease-causing change in the SGMS2 gene. This disrupts normal bone strength and can lead to the skull doughnut-like lesions and fragile bones seen in the condition.
Autosomal dominant pattern: A parent with the SGMS2 change has a 50% chance to pass it to each child. Families may see Calvarial doughnut lesions-bone fragility syndrome across several generations, though severity can differ from person to person.
First-in-family cases: Some people have a new (de novo) SGMS2 change and are the first in their family with Calvarial doughnut lesions-bone fragility syndrome. If parents test negative in blood, the chance for another child to be affected is low but not zero because a parent may carry the change in some egg or sperm cells (germline mosaicism).
Variable expression: Even with the same SGMS2 change, features can vary widely. One person may have mainly osteoporosis, while another has early skull lesions and multiple fractures.
Variant type effects: Different SGMS2 changes may be linked to different severity, including age at first fractures and whether skull lesions are prominent. Doctors sometimes see milder bone fragility with some variants and more pronounced calvarial findings with others.
Sex-neutral inheritance: Because SGMS2 is on a non-sex chromosome, all sexes have the same chance to inherit or pass on the change. Risk does not differ between boys and girls or between mothers and fathers.
Lifestyle risk factors
Calvarial doughnut lesions-bone fragility syndrome is a genetic condition; lifestyle habits do not cause it. However, daily choices can influence fracture frequency, pain, healing time, and functional independence. Understanding how lifestyle affects Calvarial doughnut lesions-bone fragility syndrome helps you reduce avoidable injuries and support bone health. Below are key lifestyle risk factors for Calvarial doughnut lesions-bone fragility syndrome and how they relate to fractures and skull involvement.
Activities with jumping, collisions, or rapid direction changes raise fracture risk in fragile long bones and the skull. Choosing lower-impact alternatives can reduce head and limb injuries without losing fitness.
Inadequate calcium intake or low vitamin D from limited sun or diet can worsen low bone mineralization in this syndrome. Consistent, age-appropriate intake supports remodeling and may reduce fracture frequency.
Prolonged inactivity weakens muscles and balance, increasing fall and fracture risk in already fragile bones. Supervised low-impact strength and balance training can improve stability without overloading the skeleton.
Tobacco toxins impair osteoblast function and blood supply, hindering bone strength and healing in this condition. Heavy alcohol use increases falls and interferes with bone remodeling, compounding fragility.
Risk prevention
Calvarial doughnut lesions-bone fragility syndrome is inherited, so you can’t prevent the condition itself, but you can lower fracture risk and avoid complications. The goal is to protect bones, prevent falls, and catch changes in the skull early. Some prevention is universal, others are tailored to people with specific risks. A care plan with your clinicians can evolve as needs change over time.
A physical therapist can build strength, balance, and posture to reduce falls. Low-impact, weight-bearing activity like walking helps bones without excessive strain. Avoid high-impact or contact sports that raise fracture risk.
Clear loose rugs and clutter, improve lighting, and add grab bars where needed. Use non-slip mats in bathrooms and sturdy handrails on stairs. Proper footwear with good grip can further cut fall risk.
Aim for enough calcium and vitamin D through food and, if needed, supplements guided by blood tests. Include protein and a varied diet to support bone repair. A registered dietitian can tailor plans for children and adults.
Do not smoke and limit alcohol, both of which weaken bone over time. Review medicines like long-term steroids with your doctor and use bone-protective strategies if they’re required. Keep caffeine and soda moderate if they replace milk or calcium-rich foods.
Transmission
Calvarial doughnut lesions-bone fragility syndrome does not spread from person to person; it isn’t contagious. The genetic transmission of Calvarial doughnut lesions-bone fragility syndrome is usually autosomal dominant, meaning a single altered copy of the gene can cause it. When a parent has the condition, each child has a 1 in 2 (50%) chance of inheriting it. In some families there’s no prior history because the change appears for the first time in the child (a new, or de novo, variant), and that child can later pass it on. Severity can vary even within the same family.
When to test your genes
Consider genetic testing if you have repeated low-impact fractures, characteristic skull “doughnut” lesions on imaging, or a strong family history of similar bone findings. Testing is also reasonable before pregnancy or in adolescence if a parent is affected, to guide monitoring and fall-prevention. Ask after unexplained osteoporosis, especially if starting bone-active therapies.
Diagnosis
Calvarial doughnut lesions-bone fragility syndrome is often suspected when people have repeat fractures or distinctive round skull spots seen on imaging. Clinicians look for a pattern of bone fragility alongside these “doughnut-like” areas in the skull. Many people feel relief just knowing what’s really going on. The genetic diagnosis of Calvarial doughnut lesions-bone fragility syndrome is confirmed with targeted testing.
Providers look for a history of fractures from minor falls, bone pain, and possible back height loss from spine compression. Headaches or scalp tenderness can occur when skull lesions are active.
Family history is often a key part of the diagnostic conversation. A similar pattern of easy fractures or skull findings across generations supports an inherited cause.
Skull X-rays or CT scans can show circular, rim-like spots in the skull bones that resemble a doughnut. These calvarial findings are a hallmark and strongly point toward this syndrome.
A series of X-rays looks for current and healed fractures and any bone shape changes. This broad view helps distinguish this syndrome from other bone disorders.
Stages of Calvarial doughnut lesions-bone fragility syndrome
Calvarial doughnut lesions-bone fragility syndrome does not have defined progression stages. Symptoms and features can vary a lot from person to person and over time, so clinicians track changes and fracture patterns rather than placing it on a scale. Early symptoms of Calvarial doughnut lesions-bone fragility syndrome may include frequent bone pain or fractures and, at times, tender bumps on the scalp, but doctors look at the overall pattern instead of a stepwise decline. Different tests may be suggested to help confirm the diagnosis, including a review of fracture history and family background, imaging of the skull and spine, bone density scanning, and, in some cases, genetic testing.
Outlook and prognosis
Falls from standing, a bump during sports, or even lifting something heavy can lead to fractures for some people with Calvarial doughnut lesions-bone fragility syndrome, so daily life often includes extra attention to bone safety and pain control. The outlook is not the same for everyone, but many living with Calvarial doughnut lesions-bone fragility syndrome remain active with the right supports, including physical therapy, protective strategies at home, and prompt treatment of fractures. Over time, most people learn their early warning signs—like new bone pain, headaches from skull lesions, or a sudden drop in height—and adjust routines to reduce risk.
Prognosis refers to how a condition tends to change or stabilize over time. For Calvarial doughnut lesions-bone fragility syndrome, fracture risk is usually highest in childhood and young adulthood, then may ease as bone density improves with age and treatment. The skull lesions tend to persist but are often stable; headaches and tenderness can flare and settle. Reported lifespan is generally near typical when fractures and their complications are managed well, though severe spine or hip fractures can carry short-term risks such as surgery, infection, or reduced mobility.
Looking at the long-term picture can be helpful. With ongoing care, many people maintain work, school, and family activities, especially when they combine fall prevention, vitamin D and calcium optimization, and targeted medications chosen by a bone specialist. Genetic testing can sometimes provide more insight into prognosis, since different gene changes may relate to how fragile the bones are and how often fractures happen. If you’re wondering about early symptoms of Calvarial doughnut lesions-bone fragility syndrome in children, watch for frequent fractures from low-impact injuries or unusual skull bumps—and ask for evaluation early, because early care can make a real difference. Talk with your doctor about what your personal outlook might look like, including how to minimize fracture risk and monitor skull lesions over time.
Long-term effects
Calvarial doughnut lesions-bone fragility syndrome is a lifelong, inherited bone condition that mainly affects bone strength and the skull bones. Long-term effects vary widely, and the course can look different from one family member to another. Many live with stable day-to-day health between fractures, while others notice ongoing bone and spine issues over time. For some, early symptoms of Calvarial doughnut lesions-bone fragility syndrome appear in childhood as frequent fractures and continue, to varying degrees, into adulthood.
A lifelong tendency toward fractures can persist, sometimes after minor falls or everyday bumps. This often starts in childhood and may continue at a slower pace in adulthood.
Bone scans may show persistently reduced bone mineral density across the lifespan. This lowers the threshold for fractures in the long term.
Compression fractures in the spine can occur over the years. These may lead to gradual height loss and a rounded upper back.
Scoliosis or kyphosis can develop or progress with repeated vertebral fractures. Posture may shift slowly, and back discomfort can become a recurring feature.
How is it to live with Calvarial doughnut lesions-bone fragility syndrome?
Living with Calvarial doughnut lesions–bone fragility syndrome often means being mindful of bones that break more easily, planning daily activities to reduce falls, and coordinating regular check-ins with specialists. Many adapt by using protective gear for sports, optimizing home safety, and prioritizing strength, balance, and vitamin D/calcium as advised by their care team. Loved ones may take on roles as encouragers and practical helpers—offering rides after appointments, helping with heavy tasks, and understanding that pain flare-ups or recovery from fractures can slow the pace of life. Over time, people often build confidence with a personalized plan, balancing caution with the activities that matter most to them.
Treatment and drugs
Treatment for Calvarial doughnut lesions–bone fragility syndrome focuses on protecting bones, preventing fractures, and easing pain. Doctors often recommend a combination of lifestyle changes and drugs: adequate calcium and vitamin D, weight‑bearing exercise as tolerated, fall‑prevention at home, and medicines that strengthen bone such as bisphosphonates when appropriate. Pain from skull lesions or fractures can be managed with simple pain relievers, short courses of stronger medicines if needed, and physical therapy to keep you moving safely. Regular follow-up with imaging and bone density checks helps tailor care, and a geneticist or metabolic bone specialist may guide testing and long‑term planning. Not every treatment works the same way for every person, so your care team may adjust the plan over time based on your symptoms, fracture history, age, and side effects.
Non-drug treatment
Living with Calvarial doughnut lesions-bone fragility syndrome often means planning daily activities to protect your bones while staying as active as you can. Beyond prescriptions, supportive therapies can reduce fracture risk, ease pain, and help you move with confidence. A team approach—physiotherapy, occupational therapy, nutrition, and counseling—usually works best and can be tailored for age and activity level. Care plans change over time, especially after injuries or surgery, so regular check-ins help keep goals realistic and safe.
Targeted exercises build strength, balance, and posture to support fragile bones. Therapists teach safe movement patterns and gradual weight-bearing.
Low-impact activities like swimming, cycling, or gentle walking help fitness without jarring the skeleton. Programs avoid high-impact or twisting moves that raise fracture risk. Try introducing one change at a time, rather than overhauling everything at once.
Home safety checks, good lighting, and non-slip mats lower the chance of falls. Supportive shoes and mobility aids can steady your steps. Vision and hearing checks also help with balance.
Custom braces or orthoses can protect weaker areas and reduce pain during activity. They also help maintain alignment while bones heal.
Your genes may have an impact on how drugs work for you
Genes can change how your body processes bone-strengthening drugs, affecting dose needs, side effects, and benefits for people with Calvarial doughnut lesions–bone fragility syndrome. Pharmacogenetic testing and careful monitoring help tailor treatment so it’s safer and more effective.
Pharmacological treatments
Medicines for Calvarial doughnut lesions-bone fragility syndrome aim to strengthen bones, lower fracture risk, and ease pain, even though research is limited due to how rare it is. Most options are adapted from treatments used for osteoporosis or brittle-bone conditions. Not everyone responds to the same medication in the same way. Your care team will tailor choices to age, fracture history, lab results, and other health needs.
Pamidronate or zoledronic acid can strengthen bone and reduce fractures in this condition. These are given by infusion at set intervals with monitoring of kidneys and mineral levels. First-line medications are those doctors usually try first, based on safety and long-term experience in fragile-bone disorders.
Alendronate or risedronate may help maintain bone density and lower fracture risk. They are taken on an empty stomach with water, staying upright afterward to protect the esophagus. Stomach upset or heartburn can occur in some people.
Daily calcium and vitamin D support bone mineralization and help anti-fracture medicines work well. Blood tests can guide dosing and avoid too much calcium. Supplements are often paired with bisphosphonates in Calvarial doughnut lesions-bone fragility syndrome.
Denosumab is an option for adults who cannot use or did not respond to bisphosphonates. It is given under the skin every 6 months with adequate calcium and vitamin D. If it is stopped, a plan to prevent rebound bone loss is needed.
Genetic influences
Families often notice a pattern of easy fractures and the round “doughnut” spots on skull imaging, which points to a genetic cause. Some conditions are passed down through families (inherited disorders). Calvarial doughnut lesions-bone fragility syndrome is most often linked to changes in the SGMS2 gene and usually follows an autosomal dominant pattern, meaning an affected parent has a 1 in 2 (50%) chance of passing it to each child. These gene changes alter how bone-forming cells work, which can lead to fragile bones and the characteristic skull lesions. New (de novo) changes can also occur for the first time, so a child may be diagnosed even when no one else in the family is known to have it. If doctors suspect it based on symptoms or imaging, genetic testing for Calvarial doughnut lesions-bone fragility syndrome can confirm the diagnosis and help guide care and family planning.
Is Calvarial doughnut lesions-bone fragility syndrome genetic?
Genetics are central in Calvarial doughnut lesions-bone fragility syndrome; most cases stem from inherited variants in the SGMS2 gene. These changes disrupt bone strength and skull bone remodeling. Family history matters, and genetic testing can confirm the diagnosis and guide relatives.
Pharmacogenetics—how genetics influence drug effects
Because calvarial doughnut lesions–bone fragility syndrome is driven by an inherited change that weakens bone, the diagnosis itself guides care, but it doesn’t usually dictate specific drug doses. There isn’t yet a therapy that targets the gene directly, and current bone‑strengthening medicines (for example, bisphosphonates or denosumab) are not typically chosen or adjusted based on drug–gene results. Where genetics can influence treatment is with supportive medicines around fractures or surgery, especially pain relievers that need to be activated by the liver. A “slow metabolizer” may process medicine more slowly, which can make codeine or tramadol less effective or raise side‑effect risk; others process these drugs very quickly and may not get pain relief at usual doses. Gene differences can also affect how long certain anti‑inflammatory pain relievers stay in the body, so your clinician may pick alternatives or adjust the dose. Confirming the genetic diagnosis of calvarial doughnut lesions–bone fragility syndrome helps tailor monitoring, physiotherapy, and fracture‑prevention strategies for your situation, while pharmacogenetic (drug–gene) testing is considered mainly to personalize supportive medications like analgesics rather than the bone‑specific drugs themselves.
Interactions with other conditions
Day-to-day, it can feel like one health issue amplifies the other when bone strength is already reduced. In Calvarial doughnut lesions-bone fragility syndrome, other conditions that thin bones—like age-related osteoporosis—or health issues that lower calcium or vitamin D (for example, gut absorption problems or long-term low intake) can raise the risk of fractures and slow healing. Certain medicines, especially long-term steroids and some seizure drugs, can also weaken bone; if they’re needed for another condition, talk with your care team about ways to protect bone. A condition may “exacerbate” (make worse) symptoms of another, so treating thyroid imbalance, celiac disease, or kidney problems can be an important part of protecting your skeleton.
Because skull spots and spine fractures can appear in several disorders, early symptoms of Calvarial doughnut lesions-bone fragility syndrome may be mistaken for more common bone conditions; clear communication among specialists helps avoid unnecessary tests and guides the right imaging and labs. Falls or balance problems from unrelated neurologic or joint issues can further increase fracture risk, so prevention strategies—safe home setup, vision checks, and targeted physical therapy—matter. Ask if any medications for one condition might interfere with treatment for another, and whether vitamin D, calcium, or bone-strengthening therapy is appropriate alongside your other care. With careful care, many people live well despite having both bone fragility and another health issue.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and neighbors once noticed a pattern: some relatives broke bones easily, and a few had small, round dents in the skull that showed up on X‑rays during dental visits or after a minor bump. Stories like these hinted that Calvarial doughnut lesions–bone fragility syndrome might run in families long before a name existed. A grandparent who healed slowly after a wrist fracture, a parent with frequent childhood breaks, a child whose head scan showed circular spots—pieces of the same puzzle appeared across generations.
Throughout history, people have described fragile bones, but the specific combination of bone fragility with ring‑shaped skull changes became clearer only in the late 20th and early 21st centuries as imaging improved. Earlier case reports noted unusual skull findings, sometimes confused with old injuries or infections. Over time, descriptions became more consistent: round, well‑defined areas in the skull bones that looked like “doughnuts” on imaging paired with a tendency toward fractures from everyday falls or low‑impact trauma.
As medical science evolved, clinicians began linking these shared features across distant families and different countries. What seemed at first like isolated, unusual X‑rays were recognized as part of a distinct pattern. With each decade, more careful documentation—what symptoms people felt, what doctors saw on exams and scans, and how often bones broke—helped separate this syndrome from other causes of brittle bones.
Advances in genetics then added the missing layer. Researchers studying families with similar skull lesions and frequent fractures found inherited changes that affected how bone forms and repairs. This confirmed what earlier generations had suspected: Calvarial doughnut lesions–bone fragility syndrome can be passed down, often showing up in multiple relatives across a family tree. Knowing this history helped explain why some families saw early symptoms of Calvarial doughnut lesions–bone fragility syndrome in childhood while others noticed issues later in adulthood.
Not every early description was complete, yet together they built the foundation of today’s knowledge. What began as scattered observations became a recognized condition with characteristic imaging findings and a family pattern. This historical path matters for people living with the syndrome today. It explains why doctors may ask about relatives’ fractures, recommend specific skull and bone imaging, and suggest genetic counseling. And it reminds us that careful listening—to family stories and to the details of each person’s experience—has always been central to understanding this condition.